Skip to content

Newsroom

type
year
Illustration image.png

8,242 Orion Corporation A shares converted into B shares

12/18/2020 Stock exchange release
Illustration image.png

Orion invests EUR 17 million in its production plants in Turku

11/10/2020 Press release
Illustration image.png

Orion Research Foundation grants 1 014 400 euros for research in 2021

11/4/2020 Press release
Turvallinen lääkehoito.jpg

Safe medication is everyone’s right

11/2/2020 Sustainability
Illustration image.png

Prosecutor pressed charges against a member of Orion’s Board of Directors for a suspected securities market offence – the suspected offence is not related to Orion

10/29/2020 Stock exchange release
Illustration image.png

Composition of the Nomination Committee of Orion Corporation

10/21/2020 Stock exchange release
Illustration image.png

Orion Group Interim Report 1-9/2020

10/21/2020 Stock exchange release
Illustration image.png

Orion upgrades full-year outlook for 2020

10/19/2020 Stock exchange release
Illustration image.png

Orion's statutory co-operation negotiations completed regarding the Research & Development function

10/19/2020 Press release
Illustration image.png

120,939 Orion Corporation A shares converted into B shares

10/19/2020 Stock exchange release
Illustration image.png

Orion publishes Interim Report for January-September 2020 on Wednesday 21 October 2020

10/6/2020 Press release
Illustration image.png

Orion is planning to renew its R&D strategy and organisation

9/10/2020 Press release
Illustration image.png

New England Journal of Medicine publishes final overall survival data for darolutamide showing treatment significantly extends life in men with non-metastatic prostate cancer

9/10/2020 Press release
Suojele_Itämerta.jpg

Save the Baltic Sea – return unused medicines to your pharmacy

8/31/2020 Sustainability
Illustration image.png

Orion Corporation: Managers’ transactions – Jari Karlson

7/31/2020 Managers transactions
Illustration image.png

Orion’s phase 3 REFALS trial evaluating the efficacy of oral levosimendan in treatment of ALS patients did not reach its pre-specified endpoints

7/28/2020 Stock exchange release
Illustration image.png

Orion Group Half-Year Financial Report 1-6/2020

7/17/2020 Stock exchange release
Illustration image.png

Orion Corporation's financial reporting and Annual General Meeting in 2021

7/17/2020 Stock exchange release